SABBY 13G VTGN 12.14.17

Company

Vistagen Therapeutics, Inc.

Filed

December 14, 2017

Accession Number

0001535610-17-000097

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →